Suliman Khan is an Associate Professor at the Second Affiliated Hospital of Zhengzhou University, China. He holds a Ph.D. in Genetics and has extensive research experience in neuroinflammation, oncology, and nanomedicine. His work focuses on the molecular mechanisms underlying neurological disorders and cancer, with particular emphasis on circadian regulation, immune signaling pathways, and targeted therapeutic strategies. Dr. Khan has authored over 100 peer-reviewed publications in high-impact journals and has been recognized among the world’s top 2% scientists (Stanford/Elsevier). He is an active member of several international scientific societies and has presented his research at leading global conferences.